The antimuscarinic agent solifenacin succinate can significantly improve symptoms of overactive bladder

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1430, 2004-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Solifenacin succinate promising in overactive bladder

By  

Inpharma, Vol. 1, Iss. 1388, 2003-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Pharmacotherapy for Overactive Bladder: An Evidence-Based Approach to Selecting an Antimuscarinic Agent

By Appell Rodney A.  

Drugs, Vol. 66, Iss. 10, 2006-01 ,pp. : 1361-1370

Adis International

Access to resources Recommend Favorite

Solifenacin in Overactive Bladder Syndrome

By Payne Christopher K.  

Drugs, Vol. 66, Iss. 2, 2006-01 ,pp. : 175-190

Adis International

Access to resources Recommend Favorite

Solifenacin in Overactive Bladder Syndrome

By Simpson Dene   Wagstaff Antona J.  

Drugs & Aging, Vol. 22, Iss. 12, 2005-01 ,pp. : 1061-1069

Adis International

Access to resources Recommend Favorite

Cardiovascular effects of antimuscarinic agents in overactive bladder

By Rosa Gian Marco   Bauckneht Matteo   Scala Carolina   Tafi Emanuela   Leone Roberti Maggiore Umberto   Ferrero Simone   Brunelli Claudio  

Expert Opinion on Drug Safety, Vol. 12, Iss. 6, 2013-11 ,pp. : 815-827

Informa Healthcare

Access to resources Recommend Favorite